Companies
- Companies
- Company details
National Jewish Health
The mission of National Jewish Health is to heal, to discover and to educate as a preeminent healthcare institution.The company in detail
Profile
National Jewish Health is known worldwide for treatment of patients with respiratory, cardiac, immune and related disorders, and for groundbreaking medical research. Founded in 1899 as a nonprofit hospital, National Jewish Health remains the only facility in the world dedicated exclusively to these disorders. Since 1998, U.S. News & World Report has ranked National Jewish Health the #1 respiratory hospital in the nation.
Partnering strategy/interests
The Technology Transfer Office at National Jewish Health embodies the spirit of the National Jewish Health brand promise, Science Transforming Life®. We accelerate the development of basic scientific research towards clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for research sponsorship, technology development, licensing, and commercialization.
Out-licensing
Adenosine A2A Receptor: A Prognosis Marker For Lung Cancer More
Anti-CD79 Antibody Offers Novel Approach to Therapy in Autoimmune Disease, Transplantation and Lymphoma More
Composition and Method for Treating Autoimmune Haemolytic Anaemia More
Elucidation of Cdk6 as a Cancer Marker and as a Target to Control Tumour Cell Growth More
High-Throughput Cell Based Assay for the Identification of Drugs Targeting the NF-kB Signalling Pathway More
Liposomal Clodronate as a Therapy For Autoimmune Haemolytic Anaemia More
Methods for Treatment of Thiol-Containing Compound Deficient Conditions: Treatment of Cystic Fibrosis More
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs More
Novel Adjuvant for Increasing Effectiveness of Vaccines More
Novel Lipid Inhibitors of TLR Effective at Reducing RSV and Influenza A Infection In Vivo More
Novel PIM 1 Kinase Inhibitor that Upregulates RUNX3 for the Treatment of Allergic Diseases More
PTPN13: A Novel Target for the Treatment of Pulmonary Fibrosis More
SERCA2: Novel Target for the Treatment of Cystic Fibrosis More
TALL-1 and its Receptor BCMA: Molecular Targets for the Development of Therapies Against Inflammatory Diseases More
Targeting a Subset of B Cells to Treat Autoimmune Diseases More
Targeting FgfR2b for the Treatment of Adult Lung Injury More
Therapy for Cystic Fibrosis using Compounds Modulating the Transport of Thiol-Containing Molecules More
Towards the Development of a Method to Prevent Biofilm Formation and Development in Cystic Fibrosis Patients More
Use of Aerosolised anti-TCR Monoclonal Antibodies as a Therapy for Airway Hyperresponsiveness, Asthma and COPD More
Use of Surfactant Phospholipids to Control Inflammation and Infection More
Use of the Listeria Monocytogenes p60 Polypeptide and Variants for Stimulating NK cells More
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 24 pages - $500
May 2011 - 15 pages - $250
Nov 2010 - 40 pages - $500
Dec 2010 - 25 pages - $500
Jan 2010 - 26 pages - $1,495
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Dec 2010 - 56 pages - $1,000
Dec 2010 - 59 pages - $500
Contact details
Dr. Emmanuel Hilaire
Manager, Technology Transfer Office
Technology Transfer
Full contact list 
Head office
National Jewish Health
Technology Transfer Office
1400 Jackson St. - M206a
Denver
Denver
80206
Colorado (USA)
Technology Transfer Office
1400 Jackson St. - M206a
Denver
Denver
80206
Colorado (USA)
Company figures
Formed: 1899
Number of employees: 1500
Number of employees: 1500
Related categories
- Industry sector
- Academic/Research / Animal health
- Academic/Research / Biotech
- Academic/Research / Diagnostic
- Academic/Research / Medical device
- Academic/Research / Pharmaceutical
- Non-profit org./Government / Patents
- Non-profit org./Government / Technology transfer
- Service / Clinical research
- Service / Research
- Service / Training
- Therapeutic target
- Allergy
- Allergy / Allergy, ophthalmic
- Allergy / Allergies (other)
- Allergy / Allergy, skin
- Allergy / Anaphylaxis
- Cardiovascular / Anemia
- Cardiovascular / Anticoagulants
- Cardiovascular / Blood clotting
- Blood and forming organs / Lymphatic disorders
- Cardiovascular
- Cardiovascular / Cerebrovascular disorders
- Cardiovascular / Acute coronary syndromes
- Cardiovascular / Cardiovascular disorder (other)
- Cardiovascular / Thrombotic disorders
- Cardiovascular / Vascular
- Cardiovascular / Blood composition
- Cardiovascular / Treatments
- Dermatological / Psoriasis
- Dermatological / Skin infection (other)
- Dermatological / Eczema
- Dermatological / Urticaria
- Dermatological / Dermatitis, atopic
- Dermatological / Chronic idiopathic urticaria
- Dermatological / Dermatitis, allergic
- Dermatological / Impetigo
- Dermatological / Lupus
- Dermatological / Scleroderma
- Genetic disorders / Genetic disorder (other)
- Genetic disorders / Kawasaki disease
- Genetic disorders / Severe combined immunodeficiency
- Hospital and Surgery / Fibrosis
- Immune related disorders
- Immune related disorders / Immunostimulation
- Immune related disorders / Immunosuppression
- Immune related disorders / Autoimmune disease (non-specific)
- Immune related disorders / Chronic fatigue syndrome
- Immune related disorders / HIV/AIDS
- Immune related disorders / Immune disorder (non-specific)
- Immune related disorders / Immune thrombocytopenic purpura
- Immune related disorders / Lupus erythematosis
- Immune related disorders / Rheumatoid arthritis
- Immune related disorders / Servere combined immunodeficency
- Immune related disorders / Systemic sclerosis
- Immune related disorders / Immunomodulation
- Infectious diseases
- Infectious diseases / Parasitic diseases
- Infectious diseases / Nosocomial infections
- Infectious diseases / Bioterrorism
- Infectious diseases / Diseases
- Infectious diseases / Treatments
- Infectious diseases / Bacteria or virus
- Metabolism / Diabetes type I
- Metabolism / Anti-oxidant
- Metabolism / Diabetes type II
- Metabolism / Diabetic complications
- Musculoskeletal / Lupus erythematosis
- Musculoskeletal / Scleroderma
- Musculoskeletal / Sjogren's syndrome
- Oncology
- Oncology / Cancer (other)
- Oncology / Anti-oxidant
- Oncology / Breast cancer
- Oncology / Leukemia
- Oncology / Lung cancer
- Oncology / Lymphoma
- Oncology / Tumor (other)
- Oncology / Cancer side effects
- Other therapeutic
- Respiratory
- Respiratory / Asthma
- Respiratory / Asthma, bronchospasm
- Respiratory / Chest disorder (other)
- Respiratory / Cough
- Respiratory / Rhinitis
- Respiratory / Nasal disorder (other)
- Respiratory / Respiratory disorder (other)
- Respiratory / Allergy, respiratory
- Respiratory / Throat disorder (other)
- Respiratory / Adult respiratory distress syndrome
- Respiratory / Bronchitis
- Respiratory / Chlamydia pneumoniae
- Respiratory / Chronic obstructive pulmonary disease
- Respiratory / Cystic fibrosis
- Respiratory / Dysplasia, bronchopulmonary
- Respiratory / Emphysema
- Respiratory / Granulomatous lung disease sarcoidosis
- Respiratory / Idiopathic respiratory distress syndrome
- Respiratory / Meconium aspiration syndrome
- Respiratory / Obstructive airway disease
- Respiratory / Pneumonocystis carinii lung infection
- Respiratory / Pneumonia
- Respiratory / Pseudomonas lung infection
- Respiratory / Respiratory syncytial virus
- Respiratory / Respiratory tract infections
- Respiratory / Rhinovirus (common cold)
- Respiratory / Sinusitis
- Respiratory / Sleep apnea
- Respiratory / Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us